Cancer can only be understood and ultimately conquered when we collaborate with a whole range of stakeholders. Of all collaboration partners, patients are by far the most important, valuable and close to our hearts.
Around 25% of our patients are engaged in a clinical study. Without their commitment, there would be no cancer research.
The worlds of the researcher in the lab and that of the patient are often miles apart. Oncode Institute and the NKI Netherlands Cancer hope to encourage researchers and patients to discover and understand each other’s worlds. This is why they collaborate in a ‘Patient Participation Program’. The Program provides a support structure that enables researchers and patients or ex-patients to connect and interact with Oncode labs. Within the NKI, four labs are involved in this program.